Equitable Holdings, Inc. Edwards Lifesciences Corp Transaction History

Equitable Holdings, Inc.

$10.1 Billion
Q4 2024

A detailed history of Equitable Holdings, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Equitable Holdings, Inc. holds 3,849 shares of EW stock, worth $271,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,849

Previous 5,333 27.83%

Holding current value

$271,200

Previous $351,000 19.09%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$64.54 - $75.92 $95,777 - $112,665	-1,484 Reduced 27.83%	3,849 $284,000
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $105,788 - $166,178	-1,772 Reduced 24.94%	5,333 $351,000
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $3,034 - $3,395	-36 Reduced 0.5%	7,105 $656,000
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $43,959 - $57,909	606 Added 9.27%	7,141 $682,000
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $120,889 - $152,331	-1,959 Reduced 23.06%	6,535 $498,000
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $622,272 - $838,739	-8,982 Reduced 51.4%	8,494 $588,000
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $533,561 - $618,238	6,554 Added 60.01%	17,476 $1.65 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $65,571 - $74,622	-883 Reduced 7.48%	10,922 $903,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $230,102 - $294,585	-3,369 Reduced 22.2%	11,805 $880,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $28,747 - $37,444	349 Added 2.35%	15,174 $1.25 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $363,300 - $538,734	-4,200 Reduced 22.08%	14,825 $1.41 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $221,355 - $278,626	2,171 Added 12.88%	19,025 $2.24 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $60,630 - $74,487	570 Added 3.5%	16,854 $2.18 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $25,727 - $30,687	250 Added 1.56%	16,284 $1.84 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $767,136 - $958,554	-9,150 Reduced 36.33%	16,034 $1.66 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $86,154 - $99,283	-1,095 Reduced 4.17%	25,184 $2.11 Million
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $130,189 - $165,673	-1,816 Reduced 6.46%	26,279 $2.4 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $93,998 - $122,328	1,399 Added 5.24%	28,095 $2.24 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.16 Million - $1.56 Million	20,214 Added 311.85%	26,696 $1.85 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $106,182 - $164,106	2,026 Added 45.47%	6,482 $1.22 Million
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $319,495 - $365,793	4,456 New	4,456 $1.04 Million

Others Institutions Holding EW

# of Institutions

1,384

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.

Account

Equitable Holdings, Inc. Edwards Lifesciences Corp Transaction History